SIX1 and neoplasm: In addition, the homozygosity of the SIX1-Q177R mutation in the tumor from which the ChIP-seq had been derived as well as the differing treatment regimens between the tumors that had been included in the ChIP-seq and RNA-seq datasets, make for imperfect comparisons.